Abstract
Nosocomial infections and infections caused by multidrug-resistant bacteria are major concern worldwide and considered sources causing numerous cases of morbidity and mortality. Given this scenario, the search for new products that are able to effectively combat the major etiologic agents involved in nosocomial infections, bacteremia and sepsis, is required. Recent studies have shown that…